SlideShare a Scribd company logo
Valld’Hebron Research Institute
Nov 15 2012




Regulation of Apoptosis by Bcl-2 Family Members
and XIAP
                                 Thomas Kaufmann
                             Institute of Pharmacology,
                           University of Bern , Switzerland
                          thomas.kaufmann@pki.unibe.ch
Necrosis              vs. Apoptosis

 passive, „accident“,       active, energy-dependent,
 alwayspathological         physiological + pathophys.

                                 cellsstayintact,
     lysis of cells
                             clearedbyphagocytosis

whole (parts of) tissue/     oftendeath of individual
   organaffected                      cells

                                no inflammation,
inducesinflammation
                                inducestolerance

                                                         2
PROGRAMMED CELL DEATH


Apoptosis
                              Necroptosis
                                 (RIPK1/3)
 Autophagic Cell Death                       NECROTIC
              Pyroptosis                     CELL DEATH
Anoikis                                      “accidents”:
               (casp-1)                      - lack of energy
                                             - physical damage
    Cornification          Pyronecrosis      - chemical damage
    (“keratinization”)




                                                                 3
TumourCellsOverexpressAnti-Apoptotic Genes
Follicular Lymphoma (spleen): t(14;18) IgH(14q32) BCL2(18q21)



                                                                BCL-2, follicular
                                       BCL-2,control              lymphoma




                                                                  germinal
                                                                   centre

                                          mantlezone




                                                                                    4
Death Receptor (Extrinsic Pathway)
                                                              Intrinsic Pathway
                                                        cytokine deprivation, DNA- damage,
                                                        hypoxia, viral infections, ER stress,
                     DISC                               anoikis, …


                    procaspase-8 (-10)
                                                            BH3-only proteins
                                                          (Bim, Puma, Bad,...)
  cFLIP          caspase-8           Bid
  cIAP1/2
                                                                                  (Bcl-2, Mcl-1,
                                         tBid                      Bcl-2-like     Bcl-xL, ...)



                                                                    Bax/Bak

            Effector Caspases          cytochrome.c
XIAP
            (-3, -6 + -7)            Caspase-9/Apaf-1
                                           Apoptosome
                             XIAP
                                                                                          5
The Bcl-2 Protein Family Regulates the Integrity of the
                      Mitochondrial Outer Membrane

                                                       BH3-only


                                                       Bcl-2-like            Bcl-2 Family


                                                          Bax-like

                    MOMP: mitochondrial outer
                    membrane permeabilisation             MOMP


                                                Smac/Diabl
                               cIAP1,2                             Cyt.c + adaptor (APAF-1)
                                                    o


                                                   XIAP

Vaux &Silke Nat Rev MCB 2005

                                            Caspase-3, -7 (, -6)             Caspase-9
                                                                                              6
Only XIAP can directly block caspases-3 and -9




                                      Riedl and Shi, Nat Rev MCB 2004




                                                                   7
Selective Interactions Between BH3-Only and Bcl-2-Like Proteins




  Bim, Bid, Puma                           ABT-737   (Oltersdorf et al
                                                      Nature 2005)
    Obatoclax   (Nguyen et al
                 PNAS 2007)




                                A1




                                              Chen et al Mol Cell 2005
                                              (modified)


                                                                         8
The Bcl-2 Family – Still Many Open Questions




                                                 BH3-only



                                                 Bcl-2-like



                                                 Bax/Bak




                    Strasser, Nat Rev Imm 2005

                                                              9
BOK: A BAX/BAK-Like Protein?
BOK: BCL-2 related ovarian killer (Hsu et al. PNAS 1997)


 BOK is widely expressed




       Ke F. et al., CDD 2012




                                                           10
BOK is Deleted in Human Cancers with high Frequency

Beroukhim et al., Nature, 2010




                                                                 11
BOK IS NOT A FUNCTIONAL BAX/BAK HOMOLOGUE

• BOK induces intrinsic apoptosis upstream of BAX/BAK
• BOK localises predominantly to non-mitochondrial sites:
    – Golgi, ER/nuclear outer membrane
    – nuclear compartment

• Bok-/- cells present with aberrant ER stress response (part. BFA)




                                          +4-OHT (h):




                                               Echeverry et al., in revision
                                                                               12
Death Receptor-Induced Killing and Crosstalk to
  Intrinsic (mitochondrial) Apoptotic Pathway




                                                  13
APOPTOSIS IS ONLY ONE OF SEVERAL POSSIBLE OUTCOMES IN DR SIGNALING




                                              FADD/C8 (?)

                                                            Proliferation
                                   cIAP1/2
      Apoptosis


                     Necroptosis


                                             NFkB




                                                            TNFa
                          cell survival




                                                                            14
TNF-R1: Not Meant to Kill


                                       TNFa

                                            TNF-R1




                                     RIP1
Apoptosis      cIAP1/2

                    Necroptosis


                                   NFkB




            anti-apoptotic genes
                                              cytokines
              => cell survival




                                                          15
LPS plus GalactosamineInjectionModelof TNF-R1-MediatedFulminant Hepatitis


• Bacterial LPS -> TNFa(Macrophages, Neutrophils, NK T)
• Response via soluble, circulating TNFa TNF-R1
(Pfeffer et al 1993, Rothe et al 1993, Grivennikov et al 2005)
• Sensitisation by D-(+)-galactosamine (GalN)
                                                                 Maeda S et al. Immunity 2003




                                                                              Kaufmann et al. (2009)

                                                                                                       16
Hepatocytesare Type IICells



TYPE I                                                   TYPE II



                                                            Bid

                                         Caspase-8
                                                           tBid


Bid      Caspase-8                                       Bcl-2-like
                                         ?   X
                                                         Bax/Bak

          Effector
         Caspases

                                           Effector         Cyt.c
                                          Caspases    Apaf1/ Caspase-9

                                                                         17
The BH3-Only Protein BIM IsRapidlyPhosphorylated in LPS/GalN-Induced Hepatitis




                                                            *




    Kaufmann et al. Immunity (2009)                                       18
Both BID and BIM areInvolved in LPS/GalN-InducedHepatitis




Kaufmann et al. Immunity (2009)
                                                                        19
BIM isActivatedby JNK MediatedPhosphorylation

A                                     B
                                                 +/- D-JNKI1 (30 mg/kg, i.p.)



           *




    Kaufmann et al. Immunity (2009)                                             20
Both BID and BIM canMediate a Crosstalk fromDeathReceptors to Mitochondria




                                       JNK
                                                   Corazza et al. JCI (2006)
                                       Bim         JNK mediated BIM-activation
                                                   downstream of TRAIL




                                                                          21
Fas/CD95/Apo-1

• FasL mainly expressed on activated T cells and natural killer cells.
• Critical role in the control of the immune system
• Fas or FasL-mutant mice develop lymphadenopathy and SLE (systemic
  lupus erythematosus)-like disease and are predisposed to lymphoma
  development
• Many ALPS patients have heterozygous inherited mutations in the
  Fasgene. (Fisher et al. Cell 1995, Rieux-Laucat et al. Science 1995)
• Only the membrane bound form of FasL is inducing cell death (O’Reilly et
  al. Nature 2009)




                                                                             22
Type I or Type II Fas-Induced Apoptotic Pathway


         FasL                                     FasL
TYPE I                                                      TYPE II


                Fas                         Fas
                                        ?                      Bid

                                       Caspase-8
                                                              tBid


Bid         Caspase-8                                       Bcl-2-like
                                       ?    X
                                                            Bax/Bak

            Effector
           Caspases

                                         Effector              Cyt.c
                                        Caspases         Apaf1/ Caspase-9

                                                                            23
ManyCancerCells Display a Mandatory Crosstalk




                                      Bcl-2


           ?   X
                                          Mitochondrium

                                X
                               MOMP
                           X
                   X
                                                          24
Aim: Uncoupling of DeathReceptorPathway




                                  Bcl-2
              drugX


                            X
                           MOMP




                                          25
CombinationTherapy




             ABT-737     Bcl-2
               ABT-737
    drug X
                     ABT-737


                MOMP




                                 26
Importance of Apoptosis in Liver
                    Pathology
Abnormal apoptosis in hepatocytes is cause or contributing factor in:

-   Viral hepatitis                      -> -> Hepatocellular carcinoma
-   Alcoholic liver disease              (HCC)

-   Autoimmune hepatitis
-   Graft-vs-host disease (GvHD)

-   Endotoxin-induced liver failure

-   Ischemia/reperfusion-induced liver damage



                                 death ligands (activated leukocytes)


                                   death receptors (hepatocytes)



                                                                          27
MurineHepatocytesare Type II-LikeCells

Jo2 anti-Fas – ALT (200 min)                                   Jo2aFas




                                         wt




wt bid-/-   lpr   wt   bid-/-   lpr

    PBS                 Jo2


     FasL (crosslinked)

                                       bid-/-
                  +FasL (0.25 mg/kg)




                                                                        scale bar: 50 mm




                                                Kaufmann et al. Cell 2007
                                                Jost et al. Nature 2009 (modified)         28
Lack of BID Blocks Fas-InducedApoptosis in Type II but not in Type I Cells




                                                 Jost PJ et al., 2009 (modified)

                                                                                   29
XIAP isStabilised in Livers of FasL-Treated WT Mice




                                       + FasL (0.25 mg/kg)




                                                                p<0.05




                                         Jost PJ et al. (2009), modified

                                                                      30
Absence of XIAP Re-SensitisesBid-DeficientMice To FasL-Induced Hepatitis




                                                         Jost PJ et al., 2009

                                                                                31
Absence of XIAP ConvertsHepatocytesInto Type I Cells




                                          DEVD-AMC Assay




                                               Jost PJ et al., 2009
                                                                      32
Effects of IAP Antagonistic Drug (BV6) Phenocopies Genetic Loss of XIAP




                                                                    33
Kaufmann, Strasser&Jost, CDD 2011


                                    34
mast cell

            35
Neutrophils: - most frequent leukocyte in human blood
             - major role in innate immunity
             - end-differentiated, short-lived
             - apoptotic clearance of activated neutrophils essential




                                                                        36
Primary Neutrophils Die By Classical Apoptosis When Cultured In Vitro


                                   C57BL/6 WT
                   100


                    80
    Survival (%)




                    60                                       untreated
                                                             GM-CSF 1ng/ml
                                                             G-CSF 10ng/ml
                    40
                                                             Q-VD oph 20uM

                    20


                    0
                         0   24   48        72     96   Time (h)




                                                                             37
Neutrophils die by Apoptosis in Response to High Doses of TNFa

             100


             80                                            wt untreated
                                                           bid-/- untreated
Survival %




             60
                                                           wt TNFa
             40                                            bid-/- TNFa


             20


              0
                   0       24       48   72         96 Time (h)

                                              100

                                               80

                                               60                                        wt TNFa

                   TNFα 50 ng/ml                                                         bid-/- TNFa
                   Q-VD oph 20 μM              40
                                                                                         wt TNFa + Q-VD-oph

                                               20                                        bid-/- TNFa + Q-VD-oph


                                                0
                                                     0        24          48   72   96                        38
FasLInduced Cell Death is Delayed In Bid-/-Neutrophils




                                        Geeringet al.Blood 2011

                                                                  39
FasL Trigger Both Apoptosis and Necroptosis in Neutrophils

               100                                                               100
                                   wt                                                           bid-/-
                80                                                                80
Survival %




                                                                    Survival %
                                                FasL                                                            FasL
                60                                                                60
                                                FasL + Q-VD-oph                                                 FasL + Q-VD-oph
                40                                                                40

                20                                                                20

                0                                                                  0
                         0   24    48      72          96 h                            0   24    48      72   96 h


                100
                                   wt                                            100            bid-/-
                80                          FasL + Q-VD-oph
                                                                                 80                             FasL + Q-VD-oph
  Survival %




                60                          FasL + Q-VD-oph + Nec   Survival %
                                                                                 60                             FasL + Q-VD-oph + Nec
                40
                                                                                 40
                20
                                                                                 20
                     0
                                                                                  0
                         0    24    48       72           96 h                                                    n>3
                                                                                       0   24    48      72   96 h



                                         FasL 100 ng/ml, Q-VD oph 20 μM, Necrostatin-1 20uM                                       40
Loss of BID Aggravates Dextran Sodium Sulfate-Induced Colitis

DSS colitis:                               -> dependent of neutrophils + macrophages
                                           -> independent of adaptive immune system

  DSS in drinking water                         water


  d0   d1   d2   d3                  d4    d5   d6   d7       d8




                                     105
                 animal weight (%)




                                     100         *      **         ***
                                                                            ***
                                     95                                           ***                     wt
                                                                                        n.s.              bid-/-
                                     90                                                        n.s.   *

                                     85
                                           0    1         2        3       4      5     6      7      8
                                                                         days


                                           => BID is anti-inflammatory
                                                                                                                   41
Proinflammatory role for BID?




                                42
Ex Vivo Generation of Neutrophils Using Conditional Hoxb8

Protocol based on Wang et al. Nature Methods 2006




                                                    d5   d0




                                                                    43
Roles of XIAP in Neutrophils




                          SCF-condHoxb neutrophils                                      SCF-condHoxb8 neutrophils

                100


                 80                              wt TNF-a




                                                                         TNFa (pg/ml)
                                                 XIAP-/- TNF-a
Viability [%]




                 60


                 40


                 20


                  0
                      0   24                48                      72
                                                            hours




                                                                                                                    44
Non-apoptotic roles of XIAP

  MDP




 NOD2         XIAP




 NFkB




cytokines                     Damgaard et al. Mol Cell 2012




                                                              45
IAPs Limit Inflammasome Activation In Macrophages




                           Vince J. et al. Immunity (2012)




                                                             46
SUMMARY
• Several poorly characterised BCL-2 family members
• Besides BID, BIM can mediate a crosstalk from DR to
  mitochondria
• XIAP is a crucial discriminator between type I and
  type II Fas-induced apoptosis
• FasL triggers mix of apoptosis and necroptosis in
  neutrophils
• Non-apoptotic roles of IAPs and DRs become
  increasingly evident (important)

                                                   47
ACKNOWLEDGMENTS
University of Bern (CH)     WEHI, Melbourne (AU)   •   Philipp Jost(Munich DE)
• NohemyEcheverry           •Andreas Strasser      •   MadsGyrd-Hansen (Kopenhagen, DK)
• UrsinaGurzeler            •Francine Ke           •   ChristophBorner (Freiburg i.Brsg., DE)
• Tatiana Rabachini         •Paul Ekert
• Daniel Bachmann                                  •   Georg Häcker(Freiburg i. Brsg., DE)
                            •John Silke
• Simone Wicki                                     •   Thomas Brunner (Konstanz, DE)
                            •David Huang
• Nicole Tochtermann                               •   Frank Essmann(Tübingen, DE)
                            •UeliNachbur
• LaetitiaRoh
                                                   •   Julia Fernandez-Rodriguez
                                                       (Gothenburg, SE)
•   Hans-Uwe Simon
•   Mario Tschan                                   •   Kurt Ballmer (Villigen, CH)
•   ShidaYousefi
•   Clemens Dahinden




                                                                                      48
LUBAC: linear ubiquitin chain assembly complex


                                                 49
Andrea L 2009
                50

More Related Content

What's hot

Oncogene and Proto-oncogene
Oncogene and Proto-oncogeneOncogene and Proto-oncogene
Oncogene and Proto-oncogene
vidan biology
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
Dr. Ishan Y. Pandya
 
Chloroplasts[1]
Chloroplasts[1]Chloroplasts[1]
Chloroplasts[1]
Dilip Pandya
 
Role of p53 gene
Role of p53 gene Role of p53 gene
Role of p53 gene
Choclaty Ashish
 
Cell cycle
Cell cycleCell cycle
Cell cycle
konmei
 
Apoptosis
ApoptosisApoptosis
Expression vectors
Expression vectorsExpression vectors
Expression vectors
Kanchan Rawat
 
Cellular Senescence Presentation
Cellular Senescence PresentationCellular Senescence Presentation
Cellular Senescence Presentation
Stephen Liu
 
programed cell death
programed cell deathprogramed cell death
programed cell death
Dr. Indrajay R. Delvadiya
 
Cell cycle regulation
Cell cycle regulationCell cycle regulation
Cell cycle regulation
RiniJoseph8
 
Apoptosis
Apoptosis Apoptosis
Apoptosis
yadavkaushal
 
Cell cycle regulation 17BCB0016
Cell cycle regulation 17BCB0016Cell cycle regulation 17BCB0016
Cell cycle regulation 17BCB0016
AkanchaAgarwal1
 
Oncogene
Oncogene Oncogene
Oncogene
Hemant Bothe
 
BIOCHEMICAL MUTATION/GENETICS
BIOCHEMICAL MUTATION/GENETICSBIOCHEMICAL MUTATION/GENETICS
BIOCHEMICAL MUTATION/GENETICS
KRISHNA VERMA
 
Transcription regulatory elements
Transcription regulatory elementsTranscription regulatory elements
Transcription regulatory elements
amirhossein heydarian
 
Genome size, organization,& gene regulation in prokaryotes (lac-operon)
Genome size, organization,& gene regulation in prokaryotes (lac-operon)Genome size, organization,& gene regulation in prokaryotes (lac-operon)
Genome size, organization,& gene regulation in prokaryotes (lac-operon)
Iqra Wazir
 
cytosceleton
cytosceletoncytosceleton
cytosceleton
wayan sugiritama
 
Complementation test; AC-DS System in Maize
Complementation test; AC-DS System in MaizeComplementation test; AC-DS System in Maize
Complementation test; AC-DS System in Maize
AVKaaviya
 
Alternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulationAlternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulation
Smrutirekha Sahu
 
Transcription factors
Transcription factorsTranscription factors
Transcription factors
NehaliBuchade
 

What's hot (20)

Oncogene and Proto-oncogene
Oncogene and Proto-oncogeneOncogene and Proto-oncogene
Oncogene and Proto-oncogene
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
 
Chloroplasts[1]
Chloroplasts[1]Chloroplasts[1]
Chloroplasts[1]
 
Role of p53 gene
Role of p53 gene Role of p53 gene
Role of p53 gene
 
Cell cycle
Cell cycleCell cycle
Cell cycle
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Expression vectors
Expression vectorsExpression vectors
Expression vectors
 
Cellular Senescence Presentation
Cellular Senescence PresentationCellular Senescence Presentation
Cellular Senescence Presentation
 
programed cell death
programed cell deathprogramed cell death
programed cell death
 
Cell cycle regulation
Cell cycle regulationCell cycle regulation
Cell cycle regulation
 
Apoptosis
Apoptosis Apoptosis
Apoptosis
 
Cell cycle regulation 17BCB0016
Cell cycle regulation 17BCB0016Cell cycle regulation 17BCB0016
Cell cycle regulation 17BCB0016
 
Oncogene
Oncogene Oncogene
Oncogene
 
BIOCHEMICAL MUTATION/GENETICS
BIOCHEMICAL MUTATION/GENETICSBIOCHEMICAL MUTATION/GENETICS
BIOCHEMICAL MUTATION/GENETICS
 
Transcription regulatory elements
Transcription regulatory elementsTranscription regulatory elements
Transcription regulatory elements
 
Genome size, organization,& gene regulation in prokaryotes (lac-operon)
Genome size, organization,& gene regulation in prokaryotes (lac-operon)Genome size, organization,& gene regulation in prokaryotes (lac-operon)
Genome size, organization,& gene regulation in prokaryotes (lac-operon)
 
cytosceleton
cytosceletoncytosceleton
cytosceleton
 
Complementation test; AC-DS System in Maize
Complementation test; AC-DS System in MaizeComplementation test; AC-DS System in Maize
Complementation test; AC-DS System in Maize
 
Alternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulationAlternative splicing : mechanism and regulation
Alternative splicing : mechanism and regulation
 
Transcription factors
Transcription factorsTranscription factors
Transcription factors
 

Viewers also liked

Apoptosis (presentation)
Apoptosis (presentation)Apoptosis (presentation)
Apoptosis (presentation)
Leo Vang
 
Cancer pathways - Communication and documentation
Cancer pathways - Communication and documentationCancer pathways - Communication and documentation
Cancer pathways - Communication and documentation
Health Informatics New Zealand
 
Apoptosis
Apoptosis Apoptosis
Bcl2 family
Bcl2 familyBcl2 family
Bcl2 family
eman youssif
 
Apoptosis
ApoptosisApoptosis
Apoptosis
Brajesh Kumar
 
Nanomedicina
NanomedicinaNanomedicina
Nanomedicina
luisaranguena
 
Apoptosis
ApoptosisApoptosis
Apoptosis
Sumana Choudhury
 
Espectroscopía Raman
Espectroscopía RamanEspectroscopía Raman
Espectroscopía Raman
Brandon Rosero Lopez
 
Apoptosis extrinsic mechanism
Apoptosis extrinsic mechanismApoptosis extrinsic mechanism
Apoptosis extrinsic mechanism
Yasha Bhardwaj
 
Apoptosis
ApoptosisApoptosis
Apoptosis
Sandhya Talla
 
11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...
11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...
11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...
Fati Naqvi
 
Kumc measuring apoptosis using flow cytometry
Kumc measuring apoptosis using flow cytometryKumc measuring apoptosis using flow cytometry
Kumc measuring apoptosis using flow cytometry
Richard Hastings
 
APOPTOSIS
APOPTOSISAPOPTOSIS
APOPTOSIS
AMORMIO34346
 
Apoptosis
ApoptosisApoptosis
Apoptosis Muerte Celular
Apoptosis Muerte CelularApoptosis Muerte Celular
Apoptosis Muerte Celular
Ursula Vargas
 
Apoptosis
ApoptosisApoptosis
Apoptosis
saquib khan
 
Necrosis Y Apoptosis
Necrosis Y ApoptosisNecrosis Y Apoptosis
Necrosis Y Apoptosis
ayquinax
 

Viewers also liked (17)

Apoptosis (presentation)
Apoptosis (presentation)Apoptosis (presentation)
Apoptosis (presentation)
 
Cancer pathways - Communication and documentation
Cancer pathways - Communication and documentationCancer pathways - Communication and documentation
Cancer pathways - Communication and documentation
 
Apoptosis
Apoptosis Apoptosis
Apoptosis
 
Bcl2 family
Bcl2 familyBcl2 family
Bcl2 family
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Nanomedicina
NanomedicinaNanomedicina
Nanomedicina
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Espectroscopía Raman
Espectroscopía RamanEspectroscopía Raman
Espectroscopía Raman
 
Apoptosis extrinsic mechanism
Apoptosis extrinsic mechanismApoptosis extrinsic mechanism
Apoptosis extrinsic mechanism
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...
11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...
11.20 (dr. yasmeen hashim) apoptosis (mechanism in normal tissues. programmed...
 
Kumc measuring apoptosis using flow cytometry
Kumc measuring apoptosis using flow cytometryKumc measuring apoptosis using flow cytometry
Kumc measuring apoptosis using flow cytometry
 
APOPTOSIS
APOPTOSISAPOPTOSIS
APOPTOSIS
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis Muerte Celular
Apoptosis Muerte CelularApoptosis Muerte Celular
Apoptosis Muerte Celular
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Necrosis Y Apoptosis
Necrosis Y ApoptosisNecrosis Y Apoptosis
Necrosis Y Apoptosis
 

Similar to Regulation of Apoptosis by BCL-2 Family Members (Prof. Thomas Kaufmann)

Advances in apoptotic pathways
Advances in apoptotic pathwaysAdvances in apoptotic pathways
Advances in apoptotic pathways
PGI Pathology Residents
 
Apoptosis regulation by BCL-2
Apoptosis regulation by BCL-2Apoptosis regulation by BCL-2
Apoptosis regulation by BCL-2
ManjuJhakhar
 
Apoptosis
ApoptosisApoptosis
Apoptosis
joshnamalempati
 
Apoptosis
ApoptosisApoptosis
Apoptosis
Mohammed Fathy
 
Apoptosis
ApoptosisApoptosis
apoptosis : The intrinsic pathway
apoptosis : The intrinsic pathwayapoptosis : The intrinsic pathway
apoptosis : The intrinsic pathway
Fatemeh710
 
Bs963 apoptosis 09-10
Bs963 apoptosis 09-10Bs963 apoptosis 09-10
Bs963 apoptosis 09-10
antavait
 
Apaptosis
Apaptosis Apaptosis
Apaptosis
Ramachandra Barik
 
Cell Death and Cancer
Cell Death and CancerCell Death and Cancer
Cell Death and Cancer
Siva Prasad
 
APOPTOSIS by dr Alfarah.pptx
APOPTOSIS by dr Alfarah.pptxAPOPTOSIS by dr Alfarah.pptx
APOPTOSIS by dr Alfarah.pptx
AlfarahIrfan
 
Apoptosis for first semester
Apoptosis   for first semesterApoptosis   for first semester
Apoptosis for first semester
Yahyea Laskar
 
Apoptosis
ApoptosisApoptosis
Apoptosis
Ruchikachauhan14
 
Apoptosis Pathway
 Apoptosis Pathway Apoptosis Pathway
Apoptosis Pathway
vidan biology
 
Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18
Sage Base
 
15 12-2011-apoptogenic factors released from mitochondria
15 12-2011-apoptogenic factors released from mitochondria15 12-2011-apoptogenic factors released from mitochondria
15 12-2011-apoptogenic factors released from mitochondria
Michele Carvalho
 
NR64192
NR64192NR64192
Apoptosis by Yatendra Singh
Apoptosis  by Yatendra SinghApoptosis  by Yatendra Singh
Apoptosis by Yatendra Singh
Yatendra Singh
 
Apoptosis in health and diseases
Apoptosis in health and diseasesApoptosis in health and diseases
Apoptosis in health and diseases
meenuev
 
Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron
Ersifa Fatimah
 
Apoptosis
ApoptosisApoptosis
Apoptosis
Imran Ahmad
 

Similar to Regulation of Apoptosis by BCL-2 Family Members (Prof. Thomas Kaufmann) (20)

Advances in apoptotic pathways
Advances in apoptotic pathwaysAdvances in apoptotic pathways
Advances in apoptotic pathways
 
Apoptosis regulation by BCL-2
Apoptosis regulation by BCL-2Apoptosis regulation by BCL-2
Apoptosis regulation by BCL-2
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
apoptosis : The intrinsic pathway
apoptosis : The intrinsic pathwayapoptosis : The intrinsic pathway
apoptosis : The intrinsic pathway
 
Bs963 apoptosis 09-10
Bs963 apoptosis 09-10Bs963 apoptosis 09-10
Bs963 apoptosis 09-10
 
Apaptosis
Apaptosis Apaptosis
Apaptosis
 
Cell Death and Cancer
Cell Death and CancerCell Death and Cancer
Cell Death and Cancer
 
APOPTOSIS by dr Alfarah.pptx
APOPTOSIS by dr Alfarah.pptxAPOPTOSIS by dr Alfarah.pptx
APOPTOSIS by dr Alfarah.pptx
 
Apoptosis for first semester
Apoptosis   for first semesterApoptosis   for first semester
Apoptosis for first semester
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis Pathway
 Apoptosis Pathway Apoptosis Pathway
Apoptosis Pathway
 
Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18
 
15 12-2011-apoptogenic factors released from mitochondria
15 12-2011-apoptogenic factors released from mitochondria15 12-2011-apoptogenic factors released from mitochondria
15 12-2011-apoptogenic factors released from mitochondria
 
NR64192
NR64192NR64192
NR64192
 
Apoptosis by Yatendra Singh
Apoptosis  by Yatendra SinghApoptosis  by Yatendra Singh
Apoptosis by Yatendra Singh
 
Apoptosis in health and diseases
Apoptosis in health and diseasesApoptosis in health and diseases
Apoptosis in health and diseases
 
Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron Microbial BBB Astroglia Neuron
Microbial BBB Astroglia Neuron
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 

More from Vall d'Hebron Institute of Research (VHIR)

Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?
Vall d'Hebron Institute of Research (VHIR)
 
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
Vall d'Hebron Institute of Research (VHIR)
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
Vall d'Hebron Institute of Research (VHIR)
 
Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...
Vall d'Hebron Institute of Research (VHIR)
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...
Vall d'Hebron Institute of Research (VHIR)
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...
Vall d'Hebron Institute of Research (VHIR)
 
Data analysis pipelines for NGS applications
Data analysis pipelines for NGS applicationsData analysis pipelines for NGS applications
Data analysis pipelines for NGS applications
Vall d'Hebron Institute of Research (VHIR)
 
NGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical viewNGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical view
Vall d'Hebron Institute of Research (VHIR)
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemicsProf. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Vall d'Hebron Institute of Research (VHIR)
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
Vall d'Hebron Institute of Research (VHIR)
 
Richard horton, barcelona 2014
Richard horton, barcelona 2014Richard horton, barcelona 2014
Richard horton, barcelona 2014
Vall d'Hebron Institute of Research (VHIR)
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
Vall d'Hebron Institute of Research (VHIR)
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Vall d'Hebron Institute of Research (VHIR)
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
Vall d'Hebron Institute of Research (VHIR)
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
Vall d'Hebron Institute of Research (VHIR)
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Vall d'Hebron Institute of Research (VHIR)
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Vall d'Hebron Institute of Research (VHIR)
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Vall d'Hebron Institute of Research (VHIR)
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
Vall d'Hebron Institute of Research (VHIR)
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
Vall d'Hebron Institute of Research (VHIR)
 

More from Vall d'Hebron Institute of Research (VHIR) (20)

Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?
 
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
 
Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...
 
Data analysis pipelines for NGS applications
Data analysis pipelines for NGS applicationsData analysis pipelines for NGS applications
Data analysis pipelines for NGS applications
 
NGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical viewNGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical view
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemicsProf. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
 
Richard horton, barcelona 2014
Richard horton, barcelona 2014Richard horton, barcelona 2014
Richard horton, barcelona 2014
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 

Regulation of Apoptosis by BCL-2 Family Members (Prof. Thomas Kaufmann)

  • 1. Valld’Hebron Research Institute Nov 15 2012 Regulation of Apoptosis by Bcl-2 Family Members and XIAP Thomas Kaufmann Institute of Pharmacology, University of Bern , Switzerland thomas.kaufmann@pki.unibe.ch
  • 2. Necrosis vs. Apoptosis passive, „accident“, active, energy-dependent, alwayspathological physiological + pathophys. cellsstayintact, lysis of cells clearedbyphagocytosis whole (parts of) tissue/ oftendeath of individual organaffected cells no inflammation, inducesinflammation inducestolerance 2
  • 3. PROGRAMMED CELL DEATH Apoptosis Necroptosis (RIPK1/3) Autophagic Cell Death NECROTIC Pyroptosis CELL DEATH Anoikis “accidents”: (casp-1) - lack of energy - physical damage Cornification Pyronecrosis - chemical damage (“keratinization”) 3
  • 4. TumourCellsOverexpressAnti-Apoptotic Genes Follicular Lymphoma (spleen): t(14;18) IgH(14q32) BCL2(18q21) BCL-2, follicular BCL-2,control lymphoma germinal centre mantlezone 4
  • 5. Death Receptor (Extrinsic Pathway) Intrinsic Pathway cytokine deprivation, DNA- damage, hypoxia, viral infections, ER stress, DISC anoikis, … procaspase-8 (-10) BH3-only proteins (Bim, Puma, Bad,...) cFLIP caspase-8 Bid cIAP1/2 (Bcl-2, Mcl-1, tBid Bcl-2-like Bcl-xL, ...) Bax/Bak Effector Caspases cytochrome.c XIAP (-3, -6 + -7) Caspase-9/Apaf-1 Apoptosome XIAP 5
  • 6. The Bcl-2 Protein Family Regulates the Integrity of the Mitochondrial Outer Membrane BH3-only Bcl-2-like Bcl-2 Family Bax-like MOMP: mitochondrial outer membrane permeabilisation MOMP Smac/Diabl cIAP1,2 Cyt.c + adaptor (APAF-1) o XIAP Vaux &Silke Nat Rev MCB 2005 Caspase-3, -7 (, -6) Caspase-9 6
  • 7. Only XIAP can directly block caspases-3 and -9 Riedl and Shi, Nat Rev MCB 2004 7
  • 8. Selective Interactions Between BH3-Only and Bcl-2-Like Proteins Bim, Bid, Puma ABT-737 (Oltersdorf et al Nature 2005) Obatoclax (Nguyen et al PNAS 2007) A1 Chen et al Mol Cell 2005 (modified) 8
  • 9. The Bcl-2 Family – Still Many Open Questions BH3-only Bcl-2-like Bax/Bak Strasser, Nat Rev Imm 2005 9
  • 10. BOK: A BAX/BAK-Like Protein? BOK: BCL-2 related ovarian killer (Hsu et al. PNAS 1997) BOK is widely expressed Ke F. et al., CDD 2012 10
  • 11. BOK is Deleted in Human Cancers with high Frequency Beroukhim et al., Nature, 2010 11
  • 12. BOK IS NOT A FUNCTIONAL BAX/BAK HOMOLOGUE • BOK induces intrinsic apoptosis upstream of BAX/BAK • BOK localises predominantly to non-mitochondrial sites: – Golgi, ER/nuclear outer membrane – nuclear compartment • Bok-/- cells present with aberrant ER stress response (part. BFA) +4-OHT (h): Echeverry et al., in revision 12
  • 13. Death Receptor-Induced Killing and Crosstalk to Intrinsic (mitochondrial) Apoptotic Pathway 13
  • 14. APOPTOSIS IS ONLY ONE OF SEVERAL POSSIBLE OUTCOMES IN DR SIGNALING FADD/C8 (?) Proliferation cIAP1/2 Apoptosis Necroptosis NFkB TNFa cell survival 14
  • 15. TNF-R1: Not Meant to Kill TNFa TNF-R1 RIP1 Apoptosis cIAP1/2 Necroptosis NFkB anti-apoptotic genes cytokines => cell survival 15
  • 16. LPS plus GalactosamineInjectionModelof TNF-R1-MediatedFulminant Hepatitis • Bacterial LPS -> TNFa(Macrophages, Neutrophils, NK T) • Response via soluble, circulating TNFa TNF-R1 (Pfeffer et al 1993, Rothe et al 1993, Grivennikov et al 2005) • Sensitisation by D-(+)-galactosamine (GalN) Maeda S et al. Immunity 2003 Kaufmann et al. (2009) 16
  • 17. Hepatocytesare Type IICells TYPE I TYPE II Bid Caspase-8 tBid Bid Caspase-8 Bcl-2-like ? X Bax/Bak Effector Caspases Effector Cyt.c Caspases Apaf1/ Caspase-9 17
  • 18. The BH3-Only Protein BIM IsRapidlyPhosphorylated in LPS/GalN-Induced Hepatitis * Kaufmann et al. Immunity (2009) 18
  • 19. Both BID and BIM areInvolved in LPS/GalN-InducedHepatitis Kaufmann et al. Immunity (2009) 19
  • 20. BIM isActivatedby JNK MediatedPhosphorylation A B +/- D-JNKI1 (30 mg/kg, i.p.) * Kaufmann et al. Immunity (2009) 20
  • 21. Both BID and BIM canMediate a Crosstalk fromDeathReceptors to Mitochondria JNK Corazza et al. JCI (2006) Bim JNK mediated BIM-activation downstream of TRAIL 21
  • 22. Fas/CD95/Apo-1 • FasL mainly expressed on activated T cells and natural killer cells. • Critical role in the control of the immune system • Fas or FasL-mutant mice develop lymphadenopathy and SLE (systemic lupus erythematosus)-like disease and are predisposed to lymphoma development • Many ALPS patients have heterozygous inherited mutations in the Fasgene. (Fisher et al. Cell 1995, Rieux-Laucat et al. Science 1995) • Only the membrane bound form of FasL is inducing cell death (O’Reilly et al. Nature 2009) 22
  • 23. Type I or Type II Fas-Induced Apoptotic Pathway FasL FasL TYPE I TYPE II Fas Fas ? Bid Caspase-8 tBid Bid Caspase-8 Bcl-2-like ? X Bax/Bak Effector Caspases Effector Cyt.c Caspases Apaf1/ Caspase-9 23
  • 24. ManyCancerCells Display a Mandatory Crosstalk Bcl-2 ? X Mitochondrium X MOMP X X 24
  • 25. Aim: Uncoupling of DeathReceptorPathway Bcl-2 drugX X MOMP 25
  • 26. CombinationTherapy ABT-737 Bcl-2 ABT-737 drug X ABT-737 MOMP 26
  • 27. Importance of Apoptosis in Liver Pathology Abnormal apoptosis in hepatocytes is cause or contributing factor in: - Viral hepatitis -> -> Hepatocellular carcinoma - Alcoholic liver disease (HCC) - Autoimmune hepatitis - Graft-vs-host disease (GvHD) - Endotoxin-induced liver failure - Ischemia/reperfusion-induced liver damage death ligands (activated leukocytes) death receptors (hepatocytes) 27
  • 28. MurineHepatocytesare Type II-LikeCells Jo2 anti-Fas – ALT (200 min) Jo2aFas wt wt bid-/- lpr wt bid-/- lpr PBS Jo2 FasL (crosslinked) bid-/- +FasL (0.25 mg/kg) scale bar: 50 mm Kaufmann et al. Cell 2007 Jost et al. Nature 2009 (modified) 28
  • 29. Lack of BID Blocks Fas-InducedApoptosis in Type II but not in Type I Cells Jost PJ et al., 2009 (modified) 29
  • 30. XIAP isStabilised in Livers of FasL-Treated WT Mice + FasL (0.25 mg/kg) p<0.05 Jost PJ et al. (2009), modified 30
  • 31. Absence of XIAP Re-SensitisesBid-DeficientMice To FasL-Induced Hepatitis Jost PJ et al., 2009 31
  • 32. Absence of XIAP ConvertsHepatocytesInto Type I Cells DEVD-AMC Assay Jost PJ et al., 2009 32
  • 33. Effects of IAP Antagonistic Drug (BV6) Phenocopies Genetic Loss of XIAP 33
  • 35. mast cell 35
  • 36. Neutrophils: - most frequent leukocyte in human blood - major role in innate immunity - end-differentiated, short-lived - apoptotic clearance of activated neutrophils essential 36
  • 37. Primary Neutrophils Die By Classical Apoptosis When Cultured In Vitro C57BL/6 WT 100 80 Survival (%) 60 untreated GM-CSF 1ng/ml G-CSF 10ng/ml 40 Q-VD oph 20uM 20 0 0 24 48 72 96 Time (h) 37
  • 38. Neutrophils die by Apoptosis in Response to High Doses of TNFa 100 80 wt untreated bid-/- untreated Survival % 60 wt TNFa 40 bid-/- TNFa 20 0 0 24 48 72 96 Time (h) 100 80 60 wt TNFa TNFα 50 ng/ml bid-/- TNFa Q-VD oph 20 μM 40 wt TNFa + Q-VD-oph 20 bid-/- TNFa + Q-VD-oph 0 0 24 48 72 96 38
  • 39. FasLInduced Cell Death is Delayed In Bid-/-Neutrophils Geeringet al.Blood 2011 39
  • 40. FasL Trigger Both Apoptosis and Necroptosis in Neutrophils 100 100 wt bid-/- 80 80 Survival % Survival % FasL FasL 60 60 FasL + Q-VD-oph FasL + Q-VD-oph 40 40 20 20 0 0 0 24 48 72 96 h 0 24 48 72 96 h 100 wt 100 bid-/- 80 FasL + Q-VD-oph 80 FasL + Q-VD-oph Survival % 60 FasL + Q-VD-oph + Nec Survival % 60 FasL + Q-VD-oph + Nec 40 40 20 20 0 0 0 24 48 72 96 h n>3 0 24 48 72 96 h FasL 100 ng/ml, Q-VD oph 20 μM, Necrostatin-1 20uM 40
  • 41. Loss of BID Aggravates Dextran Sodium Sulfate-Induced Colitis DSS colitis: -> dependent of neutrophils + macrophages -> independent of adaptive immune system DSS in drinking water water d0 d1 d2 d3 d4 d5 d6 d7 d8 105 animal weight (%) 100 * ** *** *** 95 *** wt n.s. bid-/- 90 n.s. * 85 0 1 2 3 4 5 6 7 8 days => BID is anti-inflammatory 41
  • 43. Ex Vivo Generation of Neutrophils Using Conditional Hoxb8 Protocol based on Wang et al. Nature Methods 2006 d5 d0 43
  • 44. Roles of XIAP in Neutrophils SCF-condHoxb neutrophils SCF-condHoxb8 neutrophils 100 80 wt TNF-a TNFa (pg/ml) XIAP-/- TNF-a Viability [%] 60 40 20 0 0 24 48 72 hours 44
  • 45. Non-apoptotic roles of XIAP MDP NOD2 XIAP NFkB cytokines Damgaard et al. Mol Cell 2012 45
  • 46. IAPs Limit Inflammasome Activation In Macrophages Vince J. et al. Immunity (2012) 46
  • 47. SUMMARY • Several poorly characterised BCL-2 family members • Besides BID, BIM can mediate a crosstalk from DR to mitochondria • XIAP is a crucial discriminator between type I and type II Fas-induced apoptosis • FasL triggers mix of apoptosis and necroptosis in neutrophils • Non-apoptotic roles of IAPs and DRs become increasingly evident (important) 47
  • 48. ACKNOWLEDGMENTS University of Bern (CH) WEHI, Melbourne (AU) • Philipp Jost(Munich DE) • NohemyEcheverry •Andreas Strasser • MadsGyrd-Hansen (Kopenhagen, DK) • UrsinaGurzeler •Francine Ke • ChristophBorner (Freiburg i.Brsg., DE) • Tatiana Rabachini •Paul Ekert • Daniel Bachmann • Georg Häcker(Freiburg i. Brsg., DE) •John Silke • Simone Wicki • Thomas Brunner (Konstanz, DE) •David Huang • Nicole Tochtermann • Frank Essmann(Tübingen, DE) •UeliNachbur • LaetitiaRoh • Julia Fernandez-Rodriguez (Gothenburg, SE) • Hans-Uwe Simon • Mario Tschan • Kurt Ballmer (Villigen, CH) • ShidaYousefi • Clemens Dahinden 48
  • 49. LUBAC: linear ubiquitin chain assembly complex 49